We are about to start a new clinical trial for the respiratory syncytial virus RSV. If you are over 60 years old and are interested in participating, do not hesitate to contact us.
We are about to start a new clinical trial to evaluate the efficacy and safety of a new medication for the treatment of respiratory syncytial virus – RSV.
The RSV virus (Respiratory Syncytial Virus) represents a significant threat to the health of older adults, being one of the main causes of pneumonia in this age group. At Grupo Sur Clinical Research, we are carrying out an important clinical trial to evaluate the safety and effectiveness of a new vaccine against RSV.
We are looking for committed volunteers who wish to contribute to the fight against this disease.
If you are over 60 years old and are interested in participating in our clinical trial, do not hesitate to contact us.
Enter here to participate
Queries:
Telephone: 221 3144563
Email: info.gruposurinvestigacion@gmail.com
Let’s move towards a safer and healthier future.
For more information about RSV::
Organized by:
- Grupo Sur
- Departamento de Investigación Clínica del Instituto Médico Platense
Share:
